Digitizing Pathology with AI: Transforming Disease Diagnosis with Dan Roark

Join Dan Roark, CEO and Founder of Gestalt Diagnostics, in a deep-dive conversation with Gary Fowler on why digitizing pathology is one of the most important shifts in modern healthcare. Learn how AI-powered digital pathology is reshaping disease diagnosis, accelerating clinical workflows, and improving outcomes for patients worldwide—especially in cancer care.🎯 Insights You’ll Learn:✓ Why pathology must digitize to meet modern healthcare demands✓ How AI-driven pathology improves diagnostic accuracy and speed✓ The real-world impact of Medical AI on cancer and complex diseases✓ Lessons from commercializing AI software in regulated healthcare markets✓ How AI supports pathologists rather than replacing them✓ What founders should know about building and scaling medical AI platforms🌍 Why This Matters:Pathology underpins nearly every clinical decision, yet much of it still relies on manual, analog processes. Gestalt Diagnostics is enabling a digital-first approach that unlocks AI-driven insights, helping clinicians diagnose diseases faster, more consistently, and at scale. As healthcare systems face rising demand and workforce shortages, digital pathology and AI are becoming mission-critical.👤 Expert Background:• CEO & Founder of Gestalt Diagnostics — AI-driven digital pathology software• Serial entrepreneur with multiple successful exits in life sciences• Former CEO of Matrical Bioscience (acquired by Brooks Automation)• Former VP & GM at PerkinElmer following acquisition of CCS Instruments• Holder of 10+ USPTO patents across medical imaging and automation• Deep experience across genomics, diagnostics, drug discovery, and clinical labs• Angel investor, board member, and mentor to emerging healthtech startups🎙️ Hosted by Gary Fowler, CEO of GSD Venture Studios — global AI entrepreneur, investor, and innovation leader spotlighting founders transforming industries through technology.💡 Perfect For:Healthcare innovators, medical AI founders, clinicians, pathologists, life science executives, investors, and anyone interested in the future of AI-driven diagnostics.🚀 Timely Topic:As healthcare systems push for precision medicine and faster diagnostics, AI-enabled digital pathology is emerging as a cornerstone technology—bridging human expertise with machine intelligence to save lives.Subscribe for more global founder conversations from GSD Venture Studios: https://gsdvs.com#MedicalAI #DigitalPathology #HealthcareInnovation #CancerDiagnostics #AIinHealthcare #PrecisionMedicine #HealthTech #LifeSciences #ClinicalAI #StartupLeadership #GaryFowler #DanRoark #GestaltDiagnostics #TopGlobalStartups #GSDVentureStudios